Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Am J Gastroenterol. 2021 May 1;116(5):994–1006. doi: 10.14309/ajg.0000000000001072

Table 5.

Role of PNPLA3 rs738409 as a moderator between dietary factors and fibrosis severity. Conditional effects of the dietary factors at values of the moderator using a dominant genetic model.

Bootstrapped estimates (n=10,000) Bootstrapped estimates (n=10,000)
Dietary factors Unadjusted β
coefficients
(conditional
effects)
Standard
errors
95% confidence
intervals
P value Adjusted β
coefficients
(conditional
effects)
Standard
errors
95% confidence
intervals
P value
Significant fibrosis (F≥2)
Carbohydrate (% of energy)
PNPLA3-CC 0.009 0.021 −0.033 to 0.050 .679 0.027 0.023 −0.018 to 0.073 .239
PNPLA3-GC+GG 0.025 0.013 0.000 to 0.051 .054 0.034 0.014 0.006 to 0.062 .018
n-3 PUFAs (g/day)
PNPLA3-CC −0.030 0.520 −1.049 to 0.989 .954 −0.239 0.684 −2.579 to 0.102 .070
PNPLA3-GC+GG −0.694 0.317 −1.315 to −0.074 .028 −1.844 0.540 −2.902 to −0.786 .001
Total isoflavones (mg/day)
PNPLA3-CC 0.227 0.306 −0.373 to 0.826 .458 0.313 0.350 −0.373 to 0.999 .371
PNPLA3-GC+GG −0.429 0.154 −0.731 to −0.126 .005 −0.453 0.184 −0.814 to −0.092 .014
Methionine (mg/day)
PNPLA3-CC 0.092 0.382 −0.657 to 0.840 .810 −0.741 0.514 −1.748 to 0.266 .149
PNPLA3-GC+GG −0.448 0.211 −0.862 to −0.034 .034 −1.210 0.378 −1.950 to −0.469 .001
Total choline (mg/d)
PNPLA3-CC 0.122 0.385 −0.634 to 0.877 .316 −0.729 0.514 −1.736 to 0.279 .156
PNPLA3-GC+GG −0.402 0.233 −0.859 to 0.054 .084 −1.231 0.413 −2.040 to −0.422 .003
Overall fibrosis severity (stages 0-4)
Carbohydrate (% of energy)
PNPLA3-CC 0.018 0.013 −0.008 to 0.044 .164 0.025 0.012 0.005 to 0.053 .020
PNPLA3-GC+GG 0.021 0.008 0.005 to 0.038 .011 0.029 0.008 0.010 to 0.041 .001
n-3 PUFAs (g/day)
PNPLA3-CC −0.105 0.328 −0.750 to 0.539 .749 −0.813 0.366 −1.533 to −0.093 .027
PNPLA3-GC+GG −0.521 0.199 −0.913 to −0.130 .009 −1.176 0.293 −1.752 to −0.600 <.001
Total isoflavones (mg/day)
PNPLA3-CC 0.097 0.192 −0.281 to 0.475 .614 0.138 0.190 −0.234 to 0.511 .466
PNPLA3-GC+GG −0.283 0.089 −0.458 to −0.108 .002 −0.253 0.095 −0.440 to −0.067 .008
Methionine (mg/day)
PNPLA3-CC 0.011 0.240 −0.461 to 0.484 .962 −0.523 0.277 −1.067 to 0.022 .060
PNPLA3-GC+GG −0.364 0.133 −0.625 to −0.103 .006 −0.824 0.205 −1.228 to −0.421 <.001
Total choline (mg/d)
PNPLA3-CC 0.040 0.243 −0.437 to 0.517 .869 −0.518 0.278 −1.064 to 0.028 .063
PNPLA3-GC+GG −0.353 0.148 −0.643 to −0.063 .017 -−0.864 0.224 −1.304 to −0.425 <.001

Abbreviations: PNPLA3, patatin-like phospholipase domain-containing 3; PUFAs, polyunsaturated fatty acids.

Conditional or moderation effects were calculated while adjusting for age, gender, type 2 diabetes, BMI (kg/m2) and calorie intake (kcal).

Log-transformed variables.